What is the treatment for Clostridioides (C.) difficile infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Clostridioides difficile Infection

For C. difficile infection, oral vancomycin is the recommended first-line treatment for severe cases, while oral metronidazole can be used for mild to moderate cases, with fidaxomicin as an alternative for patients at high risk of recurrence. 1

Initial Assessment and Classification

Treatment should be based on disease severity:

  • Non-severe CDI: <4 stools/day, no signs of severe colitis
  • Severe CDI: Presence of any of these markers:
    • WBC >15,000 cells/mm³
    • Serum creatinine >1.5 times baseline
    • Hypotension or shock
    • Ileus or toxic megacolon

First-Line Treatment Algorithm

Non-severe CDI (Initial Episode)

  • First choice: Metronidazole 500 mg orally three times daily for 10 days 1
  • Alternative: Vancomycin 125 mg orally four times daily for 10 days 1

Severe CDI (Initial Episode)

  • First choice: Vancomycin 125 mg orally four times daily for 10 days 1
  • Alternative: Fidaxomicin 200 mg orally twice daily for 10 days 1, 2

Fulminant CDI (Severe with complications)

  • Vancomycin 500 mg orally four times daily 1
  • PLUS Metronidazole 500 mg intravenously every 8 hours 1
  • Consider intracolonic vancomycin 500 mg in 100 mL saline as enema every 4-12 hours if ileus present 1

Management of Recurrent CDI

First Recurrence

  • Treat as per initial episode based on severity 1
  • If disease has progressed from non-severe to severe, use vancomycin 1

Second or Subsequent Recurrences

  • Vancomycin 125 mg orally four times daily for at least 10 days 1
  • Consider vancomycin taper/pulse strategy:
    • Example taper: Decreasing daily dose with 125 mg every 3 days 1
    • Example pulse: 125 mg every 3 days for 3 weeks 1
  • Alternative: Fidaxomicin 200 mg twice daily for 10 days 1
  • For multiple recurrences: Consider fecal microbiota transplantation (FMT) 1

Special Situations

When Oral Therapy Is Impossible

  • Non-severe: Metronidazole 500 mg intravenously three times daily for 10 days 1
  • Severe: Metronidazole 500 mg intravenously three times daily PLUS intracolonic vancomycin 500 mg in 100 mL saline every 4-12 hours and/or vancomycin 500 mg four times daily by nasogastric tube 1

Surgical Indications

Colectomy should be performed in:

  • Perforation of the colon
  • Systemic inflammation with deteriorating clinical condition not responding to antibiotics
  • Toxic megacolon or severe ileus
  • Consider surgery before serum lactate exceeds 5.0 mmol/L 1

Adjunctive Therapies

  • Bezlotoxumab: Consider for patients at high risk for recurrence, especially immunocompromised patients or those with severe CDI 1
  • Tigecycline: Consider only for patients who have failed standard treatments and have limited options 1
  • Probiotics: Limited evidence supports their use as adjunctive treatment 1

Important Considerations

  • Discontinue the inciting antibiotic as soon as possible 1
  • Avoid antiperistaltic agents and opiates 1
  • Provide supportive care including fluid resuscitation and electrolyte replacement 1
  • For severe cases, consider albumin supplementation if hypoalbuminemia (<2 g/dL) is present 1

Common Pitfalls to Avoid

  1. Diagnostic errors: Only test symptomatic patients (≥3 unformed stools in 24 hours) as testing cannot distinguish between colonization and infection 1
  2. Inappropriate treatment selection: Using metronidazole for severe cases or multiple recurrences 1
  3. Delayed surgical consultation: Failure to involve surgeons early in fulminant cases 1
  4. Inadequate supportive care: Neglecting fluid resuscitation and electrolyte replacement 1
  5. "Test of cure": This is not recommended after CDI treatment 1

The treatment approach should be promptly initiated based on clinical presentation, with adjustments made as needed based on patient response and disease severity.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.